ghk-cu via oral Sublingual Oral Liposomal Copper GHK
Description
It offers high purity for consistent results and comes lyophilized for improved stability and easier storage and reconstitution
Clinical trial results Sarcoidosis-associated small fiber neuropathy: In a blinded, placebo-controlled trial, 28 days of daily subcutaneous ARA-290 administration in patients with documented small nerve fiber loss produced significant improvements
However, challenges persist in regulatory harmonization across regions and the high production costs associated with pharmaceutical-grade peptide synthesis
288 , C1231C1241 (2005)
Asian J Androl 24:579583
Sign up HERE
